This bud’s for you: Amyris’s $255M cannabinoids project is dope

127

In California, we reported that Amyris signed a binding term sheet for a planned cannabinoid development, licensing and commercialization partnership valued at up to $255M (not including royalties once the products are commercialized) with a confidential partner. No, Amyris is not exactly transforming into an Industrial Budtender. Let’s look at this announce in depth.

Ga naar Bron